Search results
Results From The WOW.Com Content Network
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center is Indiana’s only National Cancer Institute-designated comprehensive cancer center – and one of only 53 in the nation.
Explore the research programs, centers and initiatives, clinical trials, shared facilities, and funding opportunities at the IU Simon Comprehensive Cancer Center. See how we are conducting cutting-edge cancer research across disciplines and stages.
IU Simon Comprehensive Cancer Center is currently home to hundreds of active clinical trials in need of participants. Discover the latest cancer clinical trials offering breakthrough treatments and innovative therapies offered at Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
CTO-BTCRC-LUN18-153. A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153. Protocol No.
Get information about the patient care services at the IU Simon Comprehensive Cancer Center. Learn about the treatment options, support services, locations and directions for cancer patients and their families.
Indiana University Melvin and Bren Simon Comprehensive Cancer Center is the central hub for cancer research and education across Indiana University. Over the last three decades, our far-reaching discoveries have changed the way cancer is treated around the world.
Setting the standard for comprehensive cancer research, education, and care. Led by Cancer Center Director Kelvin Lee, MD, our leadership and advisory teams help craft and carry out IU Simon Comprehensive Cancer Center’s strategic plan and operational activities.
At IU Simon Comprehensive Cancer Center, we have the facts you need to know about participating in a research study—and hundreds of actively recruiting clinical trials. Search Our Clinical Trials 200+ Actively recruiting clinical trials
As one of the leading academic cancer research centers in the US, the Indiana University Simon Comprehensive Cancer Center (IUSCCC) is Indiana’s only National Cancer Institute (NCI)-designated cancer center that provides patient care and fosters multidisciplinary cancer research programs.
The IU Simon Comprehensive Cancer Center aims to both retain top talent as well as recruit new members who bring various perspectives and conduct research and clinical trials that encompasses a range of experiences, backgrounds, and identities.